AI at an inflection point, but has the US mega cap tech sell-off got further to go?

In this podcast episode, Antipodes Investment Director, Alison Savas, interviews Antipodes Portfolio Manager, James Rodda.
The evolution of stock market behaviour: Interview with Antipodes’ senior trader

In this podcast episode, Antipodes Investment Director, Alison Savas, interviews Antipodes Senior Trader Steve Sevier.
State of the markets: AI inflection point, central bank gold buying & the Mag 7 stock to avoid

Alison Savas invites Antipodes’ Sector Portfolio Managers to share their insights on key sectors and stocks to watch in the new year.
Stocks to watch in 2025 (portfolio manager picks across tech, hardware, healthcare, EM & infrastructure)

Alison Savas invites Antipodes’ Sector Portfolio Managers to share their insights on key sectors and stocks to watch in the new year.
US election aftermath: Stocks to watch & how will the Fed react in 2025?

Investment implications of the 2024 United States Presidential Election
Policy, Politics & Potential: China insights with John Garnaut

Investment implications of the 2024 United States Presidential Election
Trump vs Harris: How markets will respond to the US Presidential election outcome

The investment implications of the 2024 United States Presidential Election.
Ian Harnett: Very unusual earnings concentration in US markets

Ian Harnett, Absolute Strategy Research
If the next move for rates is down should investors bother with banks?

Alison Savas and James Rodda discuss bank stocks
Foreign investors return, but can Chinese stocks thrive again? (3 China stocks to watch)

In this episode Alison Savas is joined by Antipodes Portfolio Manager, John Stavliotis to discuss the Chinese stock market.